Helix BioMedix, Inc.
Helix BioMedix, Inc.
Your view on HXBM
Overview
What the company does, where it operates, and who runs it.
About Helix BioMedix, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Robin L. Carmichael
- Headquarters
- 22121-17th Avenue SE, Bothell, WA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Robin L. Carmichael
- Headquarters
- 22121-17th Avenue SE, Bothell, WA, US
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.